Tempus, Pfizer Partner to Advance Oncology Therapeutic Development
Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified to power therapeutic development in oncology.
Source: hitconsultant.net
Pfizer Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pfizer Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pfizer Partner Today - Breaking & Trending Today
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
Vysioneer, a provider of applied AI for Oncology, today announced a data sharing agreement with Pfizer, a global leader in pharmaceuticals.
Source: hitconsultant.net
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
Multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG).
Source: hitconsultant.net